Wednesday, June 10, 2026
🇺🇸 FDA

Intelligence · Patents

Patents expiring in 2032

Annual patent cliff calendar for 2032 — US pharmaceutical patents by expiration date.

Patents
1,150

Quick answer

1,150 indexed pharmaceutical patents have expiration dates in 2032. Browse by soonest expiry with links to assignee companies and related drugs.

  1. US 8244344

    Drug releasing coatings for medical devices

    Lutonix, Inc. · Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8242170

    Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy

    The Regents of the University of California · Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8242080

    Inhibitors of the EGFR kinase targeting the asymmetric activating dimer interface

    The Regents of the University of California · Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8242093

    Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

    Ceregene, Inc. · Granted Tue Aug 14 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8247564

    Compounds having BETA2 adrenergic receptor agonist and muscarinic receptor antagonist activity

    Theravance, Inc. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8246969

    Compositions containing aromatic aldehydes and their use in treatments

    SkinMedica, Inc. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8246987

    Controlled release composition and method of producing the same

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8247183

    Compositions and methods for diagnosis and treatment of tumors

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8247228

    Method of inducing memory B cell development and terminal differentiation

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8247403

    Benzoxazepine derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8247443

    Small molecule antagonists of bacterial quorum-sensing receptors

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8247598

    Methods for the formation of hydrogels using thiosulfonate compositions and uses thereof

    Nektar Therapeutics · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8247602

    Antagonists of prostaglandin D2 receptors

    Panmira Pharmaceuticals, LLC · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8247399

    Photoactive metal nitrosyls for blood pressure regulation and cancer therapy

    The Regents of the University of California · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8247225

    DNA promoters and anthrax vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8247393

    Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof

    TEVA WOMEN'S HEALTH, INC. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8247181

    Borrelia diagnostics and screening methods

    The Regents of the University of California · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8246931

    Development of a quail embryo model for the detection of botulinum toxin

    The United States of America, as represented by the Secretary of Agriculture · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8246952

    Method of increasing radiation sensitivity by inhibition of beta one integrin

    The Regents of the University of California · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8247174

    Methods of diagnosing endometriosis

    The Regents of the University of California · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8246971

    Compositions containing aromatic aldehydes and their use in treatment

    SkinMedica, Inc. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8246983

    Encapsulated arsenic drugs

    Northwestern University · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8246984

    Formulation of insoluble small molecule therapeutics in lipid-based carriers

    Rigel Pharmaceuticals, Inc. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8247429

    Tricyclic compound and pharmaceutical use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8247433

    Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

    Theravance, Inc. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8247420

    Compositions, synthesis, and methods of using quinolinone based atypical antipsychotic agents

    REVIVA PHARMACEUTICALS, INC. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8247410

    Pyrimidine substituted purine derivatives

    VERASTEM, INC. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8247421

    5-cyano-4-(pyrrolo [2,3B] pyridine-3-yl)-pyrimidine derivatives useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8247536

    Factor VIII compositions

    Nektar Therapeutics · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8247550

    Certain substituted amides, method of making, and method of use thereof

    GILEAD CONNECTICUT, INC. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8247555

    Crystalline forms of an 8-azabicyclo[3.2.1]octane compound

    Theravance, Inc. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8247563

    Compositions, synthesis, and methods of using indanone based cholinesterase inhibitors

    REVIVA PHARMACEUTICALS, INC. · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8247532

    Deuterated hepatitis C protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 21 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8252541

    Sodium channel protein type III α-subunit splice variant

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8252538

    MicroRNA expression signature for predicting survival and metastases in hepatocellular carcinoma

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8252574

    Pseudoinfectious flavivirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8252737

    Antimicrobial peptides and methods of use

    The Regents of the University of Colorado · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8252545

    Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8252338

    Synthetic LDL as targeted drug delivery vehicle

    The Regents of the University of California · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8252550

    Targeting poly-γ-glutamic acid to treat Staphylococcus epidermidis and related infections

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8252923

    Peptidomimetic protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8252836

    Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

    The Board of Regents of the University of Texas System · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8252791

    Purine compounds as cannabinoid receptor blockers

    Jenrin Discovery, LLC · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8252578

    Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8252764

    Compositions and methods of use of targeting peptides against placenta and adipose tissues

    The Board of Regents of the University of Texas System · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8252767

    Substituted 4-{3-[6-amino-9-(3, 4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

    Dogwood Pharmaceuticals, Inc. · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8252756

    Nucleic acid functionalized nanoparticles for therapeutic applications

    Northwestern University · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8252787

    Protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Tue Aug 28 2012 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 23 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2032?

1,150 published patents in our USPTO index have expiration dates falling in calendar year 2032.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.